How this fund's holdings score on the six lenses, weighted by holding weight — plus what the manager is actively buying and selling. A transparency roll-up of the stock atom — descriptive, not a forecast of outperformance.
What's a “leader”? A holding that ranks in the top two deciles (D9 / D10) of its size cohort on BOTH active conviction lenses — Technical and Flow. Leadership-breadth is the share of the fund's weight sitting in those leaders.
Risk & return
Compound returns and the risk taken to earn them, from the fund's own NAV history.
| Sector | 11 Jul | 18 Jul | 25 Jul | 24 Aug | 28 Aug | 04 Sep | Δ |
|---|---|---|---|---|---|---|---|
| Pharma | 49.8 | 50.8 | 50.8 | 53.2 | 53.2 | 53.2 | +3.4 |
| Healthcare | 35.3 | 34.8 | 34.8 | 34.1 | 34.1 | 34.1 | -1.2 |
| Chemicals | 6.7 | 6.5 | 6.5 | 6.2 | 6.2 | 6.2 | -0.5 |
| Unclassified | 4.0 | 3.6 | 3.6 | 4.4 | 4.4 | 4.4 | +0.4 |
Glass box
Click a lens to expand its holdings, ranked by contribution (weight × decile); each name links to its own evidence. Descriptive, not a forecast.
—
—
| Symbol | Sector | Weight | Tch | Fnd | Cat | Flw | Val | Lead | RS 3M |
|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | Pharma | 8.53% | 7 | 8 | 7 | 8 | 5 | — | +1.5% |
| TORNTPHARM | Pharma | 7.81% | 7 | 8 | 5 | 4 | 1 | — | +7.0% |
| LAURUSLABS | Pharma | 4.94% | 9 | 9 | 3 | 3 | 1 | — | +29.2% |
| APOLLOHOSP | Healthcare | 4.78% | 9 | 5 | 5 | 2 | 2 | — | +0.4% |
| DIVISLAB | Pharma | 3.86% | 9 | 8 | 1 | 4 | 1 | — | +38.4% |
| MAXHEALTH | Healthcare | 3.76% | 1 | 9 | 6 | 5 | 6 | — | -6.0% |
| CIPLA | Pharma | 3.72% | 4 | 3 | 6 | 4 | 7 | — | -3.9% |
| SAILIFE | Healthcare | 3.18% | 9 | 10 | 5 | 9 | 1 | Leader | +27.8% |
| ZYDUSLIFE | Pharma | 2.94% | 9 | 10 | 10 | 2 | 8 | — | +1.9% |
| NEULANDLAB | Healthcare | 2.87% | 8 | 10 | 7 | 4 | 1 | — | +30.4% |
| LALPATHLAB | Healthcare | 2.53% | 7 | 8 | 7 | 5 | 3 | — | +18.6% |
| CORONA | Pharma | 2.44% | 5 | 9 | 7 | 2 | 1 | — | +14.6% |
| AUROPHARMA | Pharma | 2.42% | 8 | 3 | 10 | 6 | 7 | — | +9.9% |
| KIMS | Healthcare | 2.34% | 4 | 3 | 6 | 10 | 2 | — | -9.0% |
| FORTIS | Healthcare | 2.20% | 4 | 8 | 5 | 5 | 6 | — | -12.4% |
| THYROCARE | Pharma | 2.20% | 7 | 10 | 8 | 9 | 2 | — | +1.4% |
| NH | Healthcare | 1.82% | 5 | 8 | 7 | 10 | 4 | — | -4.9% |
| AJANTPHARM | Pharma | 1.81% | 8 | 10 | 1 | 3 | 3 | — | +13.9% |
| PGHL | Pharma | 1.70% | 4 | 4 | 1 | 8 | 5 | — | -13.0% |
| RAINBOW | Healthcare | 1.61% | 10 | 7 | 4 | 3 | 4 | — | +5.0% |
| GRANULES | Healthcare | 1.56% | 10 | 9 | 5 | 6 | 6 | Leader | +8.7% |
| VIJAYA | Pharma | 1.53% | 7 | 10 | 5 | 4 | 1 | — | +10.1% |
| AETHER | Chemicals | 1.47% | 7 | 9 | 4 | 3 | 1 | — | +38.1% |
| ANTHEM | Pharma | 1.47% | 10 | 10 | 6 | 3 | 1 | Leader | +16.3% |
| NAVINFLUOR | Chemicals | 1.46% | 9 | 10 | 4 | 8 | 1 | Leader | +20.9% |
| ACUTAAS | Chemicals | 1.44% | 5 | 10 | 3 | 8 | 2 | — | -8.5% |
| SHAILY | Chemicals | 1.39% | 10 | 10 | 3 | 4 | 1 | Leader | +4.3% |
| MEDANTA | Healthcare | 1.18% | 8 | 9 | 5 | 4 | 2 | — | +13.1% |
| ONESOURCE | Healthcare | 1.18% | 3 | 1 | 6 | 7 | 8 | — | -15.1% |
| IPCALAB | Pharma | 1.12% | 9 | 5 | 1 | 3 | 4 | — | +14.3% |
| INNOVACAP | Pharma | 1.10% | 10 | 8 | 6 | 2 | 2 | — | +29.4% |
| JLHL | Healthcare | 1.07% | 1 | 9 | 4 | 2 | 10 | — | -83.0% |
| PFIZER | Healthcare | 1.03% | 5 | 7 | 1 | 8 | 7 | — | -2.9% |
| POLYMED | Healthcare | 0.91% | 6 | 6 | 5 | 6 | 6 | — | +18.6% |
| GLAND | Pharma | 0.91% | 10 | 7 | 5 | 4 | 4 | Leader | +27.9% |
| SENORES | Pharma | 0.85% | 9 | 10 | 8 | 4 | 2 | Leader | +44.3% |
| AARTIPHARM | Pharma | 0.85% | 10 | 3 | 4 | 1 | 3 | — | +37.8% |
| VIMTALABS | Pharma | 0.76% | 8 | 8 | 5 | 9 | 7 | — | +17.1% |
| NEPHROPLUS | Healthcare | 0.67% | 6 | 5 | 6 | 5 | 9 | — | +2.5% |
| SUPRIYA | Pharma | 0.60% | 6 | 10 | 5 | 8 | 3 | — | -5.5% |
| BIOCON | Pharma | 0.54% | 4 | 1 | 10 | 2 | 7 | — | -8.8% |
| TATVA | Chemicals | 0.47% | 9 | 8 | 5 | 2 | 1 | Leader | +44.3% |
| ZOTA | Pharma | 0.45% | 4 | 5 | 10 | 4 | 10 | — | -13.9% |
| SUDEEPPHRM | Pharma | 0.37% | 6 | 9 | 2 | 2 | 1 | — | +76.9% |
| ORCHPHARMA | Pharma | 0.27% | 7 | 1 | 4 | 10 | 2 | — | +8.0% |
| COHANCE | Healthcare | 0.21% | 4 | 5 | 6 | 3 | 5 | — | +1.5% |
Performance · 2.6y
Over the last 2.6 years ₹100 in the fund grew to ₹169 (+69%), vs ₹115 for Nifty 500 (+15%) and ₹108 for Nifty 50 (+8%). Its relative-strength line ended at 156 vs Nifty 50 and 147 vs Nifty 500 — above 100, sustained outperformance.